$PAVM News

Last published 1w ago

1w agoPAVM LUCDPAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026PR NewswireConference Call and Webcast at 8:30 AM ETNEW YORK, Oct. 30, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company,
1w agoLUCD PAVMLucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026PR NewswireConference Call and Webcast at 8:30 AM ETNEW YORK, Oct. 29, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics
2w agoLUCD PAVMLucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million FinancingPR NewswireLucid is now submitting Medicare claims and receiving payments at EsoGuard's established Clinical Laboratory Fee Schedule rateSeries C Preferred Stock private placement with existing long-term shareholders
2mo agoPAVM LUCDPAVmed Provides Business Update and Reports Second Quarter 2026 Financial ResultsPR NewswireVeris Health accelerated its commercial engagement with OSU-The JamesVeris Health implantable physiological monitor achieved development milestones towards upcoming FDA submissionLucid Diagnostics secured first
3mo agoLUCD PAVMLucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial ResultsPR NewswireRecognized 2Q26 revenue of $1.5 millionProcessed 2,770 EsoGuard ® testsSecured first laboratory benefit manager (LBM) EsoGuard coverage policyConference call and webcast to be held today, August 13, at 8:30 AM EDTNEW
3mo agoLUCD PAVMLucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA TestPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
3mo agoLUCD PAVMLucid Diagnostics to Participate in Upcoming Investor ConferencesPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
3mo agoPAVM LUCDPAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026PR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
3mo agoLUCD PAVMLucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
6mo agoPAVM LUCDPAVmed Provides Business Update and Reports First Quarter 2026 Financial ResultsPR NewswirePAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
6mo agoLUCD PAVMLucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial ResultsPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
6mo agoPAVM LUCDPAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026PR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
6mo agoLUCD PAVMLucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of...
6mo agoLUCD PAVMLucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common StockPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
6mo agoLUCD PAVMLucid Diagnostics Announces $18 Million Underwritten Offering of Common StockPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
7mo agoLUCD PAVMLucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare ConferencePR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
7mo agoPAVM LUCDPAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device PortfolioPR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
7mo agoPAVM LUCDPAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsPR NewswirePAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
8mo agoPAVM LUCDPAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026PR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
8mo agoLUCD PAVMLucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of...
9mo agoPAVM LUCDPAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible SecuritiesPR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
9mo agoLUCD PAVMLucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
10mo agoPAVM LUCDPAVmed Announces Reverse Stock SplitPR NewswirePAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
11mo agoLUCD PAVMLucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer DetectionPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
11mo agoLUCD PAVMLucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking HonoreePR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
12mo agoLUCD PAVMLucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
12mo agoPAVM LUCDPAVmed Provides Business Update and Reports Third Quarter 2025 Financial ResultsPR NewswirePAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
12mo agoLUCD PAVMLucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial ResultsPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
1y agoPAVM LUCDPAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025PR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
1y agoLUCD PAVMLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of...
1y agoLUCD PAVMLucid Diagnostics to Participate in the 2025 Maxim Growth SummitPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
1y agoPAVMPAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership AgreementPR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device,...
1y agoLUCD PAVM ABC MDRXLucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of DirectorsPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
1y agoLUCD PAVMLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage cancer prevention medical diagnostics company and subsidiary of...
1y agoLUCD PAVMLucid Diagnostics Announces Closing of Public Offering of Common StockPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
1y agoLUCD PAVMLucid Diagnostics Announces Pricing of Public Offering of Common StockPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
1y agoLUCD PAVMLucid Diagnostics Announces Proposed Public Offering of Common StockPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
1y agoLUCD PAVMLucid Diagnostics to Host Investor Call on Monday, September 8, 2025PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
1y agoLUCD PAVMLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
1y agoPAVM LUCDPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyPR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
1y agoPAVM LUCDPAVmed Provides Business Update and Reports Second Quarter 2025 Financial ResultsPR NewswirePAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
1y agoLUCD PAVMLucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial ResultsPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
1y agoLUCD PAVMLucid Diagnostics to Participate in Upcoming Investor ConferencesPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
1y agoPAVM LUCDPAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025PR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
1y agoLUCD PAVMLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025PR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of...
1y agoPAVM LUCDPAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RulePR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device,...
1y agoLUCD PAVMMolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA TestPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of ...
1y agoPAVMPAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity FinancingPR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company operating in the medical device,...
1y agoLUCD PAVMMajor California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA TestPR NewswireLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
1y agoPAVMPAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstitutePR NewswirePAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device,...